Patents by Inventor Dan R. Burns

Dan R. Burns has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods For Treating Hyperbilirubinemia With Stannsoporfin And Phototherapy
    Publication number: 20200001109
    Abstract: Methods of treating hyperbilrubinemia or reducing total serum bilirubin levels include initiating phototherapy on an infant while substantially simultaneously administering to the infant a therapeutic amount of stannsoporfin. Various embodiments are directed to treating hyperbilirubinemia and decreasing bilirubin levels.
    Type: Application
    Filed: May 12, 2017
    Publication date: January 2, 2020
    Inventors: Dan R. BURNS, Simon J. TULLOCH
  • Method for monitoring proteasome inhibitor drug action
    Patent number: 6613541
    Abstract: The invention relates to methods for measuring proteasome activity in biological samples. More particularly, then invention relates to methods for monitoring drug action following in vivo administration of a proteasome inhibitor. The invention provides methods and kits for monitoring pharmacodynamic drug action and for determining dose regimen for a proteasome inhibitor. The invention also provides methods for determining baseline proteasome activity in a mammal.
    Type: Grant
    Filed: October 19, 1999
    Date of Patent: September 2, 2003
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Gopalakrishna R. Vaddi, Ross L. Stein, Lawrence R. Dick, Vito J. Palombella, Eric S. Lightcap, Peter J. Elliott, Julian Adams, Teresa A. McCormack, Stephen J. Brand, Dan R. Burns